QHB-29538-07099
2 vaccinations
1 coded response
15 check-ins
1 free-text entry
1 call case
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 222 / VA
- Registered
- 2021-03-06
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-06
Registered in v-safe
-
2021-03-06
Dose 1 — Janssen/Johnson & Johnson
- 2021-03-06
-
2021-03-07
Health check-in — days 1–6 daily, dose 1Feeling: Poor · Site: Pain · Chills, Headache, Joint pains, Muscle or body aches, Nausea · Be unable to do your normal daily activitiesAdult check-in
- 2021-03-08
- 2021-03-09
- 2021-03-10
- 2021-03-11
- 2021-03-20
- 2021-03-27
- 2021-04-17
- 2021-09-06
-
2021-10-22
Dose 2 — Moderna
- 2021-10-31
- 2021-11-05
- 2021-11-12
- 2022-04-22
-
2022-10-22
Survey response — 12 months, dose 2MedDRA: Thrombosis — Feeling: Fair · Get care from a doctor or other healthcare professional · HospitalizationFree text: Blood clotMedDRA releases: 2024-11 · check-in free text available
-
2022-10-22
Report sent to call center — 12 months, dose 2Get care from a doctor or other healthcare professionalHospitalization · 1 call case(s)
-
2022-10-25
Call successfulParticipant prefers to complete VAERS report online
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-06 | Janssen/Johnson & Johnson | |
| 2 | 2021-10-22 | Moderna | No |
Call center
1 call center case
1 successful
Free text
Release 12 — 12 months, dose 2
Symptoms: Blood clot
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Thrombosis | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release